Company profile: Quanterix
1.1 - Company Overview
Company description
- Provider of ultrasensitive biomarker detection solutions for healthcare, leveraging Simoa technology to enable earlier disease detection and improved treatment by measuring biomarkers at lower levels. Offerings include Simoa assays across neurology, oncology, cardiology, immunology and infectious disease; the HD-X automated immunoassay analyzer; SP-X and SR-X detection systems; and the CLIA-certified Simoa Accelerator Laboratory.
Products and services
- HD-X Automated Immunoassay Analyzer: An industrial-grade, fully automated immunoassay platform that delivers multiplexing and custom assay capabilities with up to 1000x greater sensitivity for biomarker detection
- Simoa Technology: An ultrasensitive digital health system that measures biomarkers at lower levels to enable the development of earlier disease detection methods and improved treatment methods
- Simoa Accelerator Laboratory: A CLIA-certified laboratory service utilizing Simoa technology for advanced biomarker research and drug development
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Quanterix
QuantuMDx
HQ: United Kingdom
Website
- Description: Provider of handheld and portable low-cost diagnostic and genomic sequencing platforms, including the Q-POC rapid multiplex PCR point-of-care system; assays for SARS-CoV-2, Flu A/B, RSV; a research-use TB host immune response assay; a saliva-based SARS-CoV-2 RT-PCR test; CAPTURE-XT lab-on-chip pathogen concentration; and microarray technologies for high-throughput genetic marker screening.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full QuantuMDx company profile →
Bioline
HQ: United Kingdom
Website
- Description: Provider of fast, easy-to-use, guaranteed-to-work products developed by scientists to help customers focus on their scientific goals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioline company profile →
NorthGene
HQ: United Kingdom
Website
- Description: Provider of medical testing, health care and other services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NorthGene company profile →
Select Immunogenomics
HQ: United States
Website
- Description: Provider of data analysis, predictive modeling, and reporting in support of genomic studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Select Immunogenomics company profile →
Syngenta
HQ: Switzerland
Website
- Description: Provider of agricultural technologies and solutions that improve yields, crop resilience, and resource conservation. Offers crop protection from sowing to harvest; seeds and traits for grains, oilseeds, vegetables, fruits, and flowers; TYMIRIUM technology against nematodes and soil-borne pathogens; PERGADO Ultra fungicide for cocoa; and Shoots by Syngenta, a collaborative platform advancing sustainable agriculture.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syngenta company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Quanterix
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Quanterix
2.2 - Growth funds investing in similar companies to Quanterix
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Quanterix
4.2 - Public trading comparable groups for Quanterix
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →